I would certainly agree.
Perhaps I'll direct the attention of the clerk to flag for the members afterwards in the report, under the monitoring and surveillance recommendations, point one in particular. It's really to standardize the key elements of the prescription drug surveillance system in Canada.
That's really for the federal government; professional associations; the Institute for Safe Medication Practices, which was identified as well; and the provinces and territories. I think there is absolutely a need for consistent national data collection. That means talking to the data holders, which are often the provinces, and looking at the different data streams that would come from that. It could be coroner reports and poison centre reports, as was mentioned earlier.
The bane of existence in these matters is common terminology. This includes a definition of how we're quantifying, what is the effect and impact of these, and the collection methods and the reporting.
As to the actual specific federal role, I think we could look to roles that the federal government plays in other national data collection mechanisms. Certainly the ability to have one understanding of what's going on in the country, as fed into by the provinces, would be useful.